Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)

• Published in: Journal of cardiovascular magnetic resonance 2021-05, Vol.23 (1), p.52-17, Article 52
• Main Authors: Ordovas, Karen G, Baldassarre, Lauren A, Bucciarelli-Ducci, Chiara, Carr, James, Fernandes, Juliano Lara, Ferreira, Vanessa M, Frank, Luba, Mavrogeni, Sophie, Ntusi, Ntobeko, Ostenfeld, Ellen, Parwani, Purvi, Pepe, Alessia, Raman, Subha V, Sakuma, Hajime, Schulz-Menger, Jeanette, Sierra-Galan, Lilia M, Valente, Anne Marie, Srichai, Monvadi B
• Format: Article
• Language: English
• Subjects: Acute coronary syndromes; Aorta; Aortic valve; Associations, institutions, etc; Cardiac and Cardiovascular Systems; Cardiomyopathy; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - diagnostic imaging; Cardiovascular Diseases - therapy; Cardiovascular magnetic resonance; Clinical Medicine; Collagen; Congenital heart disease; Coronary artery disease; Decision making; Female; Gender differences; Genetic disorders; Health aspects; Heart Defects, Congenital; Heart diseases; Heart valves; Humans; Ischemia; Kardiologi; Klinisk medicin; Magnetic resonance; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Medical and Health Sciences; Medical imaging; Medicin och hälsovetenskap; Mutation; Position statement; Predictive Value of Tests; Resonance; Review; Rheumatic diseases; Rheumatic heart disease; Societies; Society for Cardiovascular Magnetic Resonance; Tomography; Women
• ISSN: 1097-6647; 1532-429X; 1532-429X
• DOI: 10.1186/s12968-021-00746-z

This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR.